Yttrium-90 (Y-90) has long been used to treat liver cancer. Researchers are exploring its potential to treat diseases in other sites, but a number of obstacles have made progress halting.
As liquid biopsies inch closer to becoming a standard of care, questions about their efficacy, use and role in cancer diagnosis and treatment abound. Discordant research findings between liquid and tissue biopsies only add to the confusion.
French company BodyCap has gained Europe’s CE Mark for an ingestible pill that permits wireless core body temperature measurement.
The e-Celsius device enables clinicians to continuously measure a patient’s temperature via the GI tract. Patients swallow the electronic...
When women who are at high risk for breast cancer and have undergone mammography get a letter describing options for further imaging with contrast-enhanced MRI of the breast, they are more apt to return for follow-up screening,...
Image courtesy of Level EX Airway EX Mobile App
A new 3-D virtual surgery app by technology company Level EX draws on the knowledge of leading surgeons and video game developers to help physicians sharpen their minimally invasive surgical skills for procedures involving the airway....
With the right strategy, health system CEOs can leverage online outlets to improve the reach of their hospitals’ voice and engage a population hungry for information and perspective.
Rated one of the nation’s top physicians for patient satisfaction in 2015, Gregory Lowe, MD, urologic surgeon and sexual medicine specialist at OhioHealth Urology Physicians, merges high-level expertise with state-of-the-art devices and techniques to treat erectile dysfunction (ED) and male urinary incontinence (UI).
Just 66 percent of the nation’s largest hospitals have mobile apps for patients to use, and of those that furnish apps, only 2 percent of their patient populations utilize them, according to recent research by consulting firm Accenture. That’s a costly gap that experts say hospitals can close.
Many scientists believe the failure of chemotherapy and radiation therapy to kill cancer stem cells leads to relapses. A new device may allow more accurate determination of whether emerging treatments targeting those particularly dangerous cells are...
The EHR adoption rate among physicians in the United States is high — greater than 80 percent, according to federal government data — but with federal meaningful use (MU) incentives drying up, what will it take to get the holdouts on board?
- 1 of 12
- next ›